PMID- 7108445 OWN - NLM STAT- MEDLINE DCOM- 19821012 LR - 20190508 IS - 0022-1007 (Print) IS - 1540-9538 (Electronic) IS - 0022-1007 (Linking) VI - 156 IP - 3 DP - 1982 Sep 1 TI - Deregulation of idiotype expression. Induction of tolerance in an anti-idiotypic response. PG - 898-911 AB - The induction of tolerance in an anti-idiotypic response was attempted by in vivo exposure to excess idiotype. Monoclonal immunoglobulin from the anti-p-azobenzenearsonate (ABA) hybridoma R16.7 was used as a representative of cross-reactive idiotype-positive (CRI+) antibodies because this hybridoma protein (HP) shares one or more closely related public idiotypic determinants with the serum CRI in A/J mice. Immunologic unresponsiveness was established by a single injection of the R16.7 idiotype and persisted for at least 6 wk. The level of circulating anti-idiotypic antibodies in tolerized A/J mice was significantly depressed after immunogenic challenge with eigher antigen, ABA-keyhole limpet hemocyanin (KLH), or the idiotype R16.7 HP. Experimental depletion of anti-idiotypic antibodies by tolerization allowed assessment of immunoregulation within this altered idiotype-anti-idiotype network. Deregulation of idiotype expression in tolerized mice challenged with ABA-KLH was manifest with up to 96% of the anti-ABA antibodies cross-reacting with the R16.7 idiotype. This selective enhancement of a major idiotype was accomplished without substantial alteration of the level of the overall anti-hapten response. Both the unresponsiveness established in anti-idiotypic antibody-producing cells and the enhanced synthesis in idiotype-producing cells were stable upon adoptive transfer into lethally irradiated, syngeneic recipients. Finally, previous immunization with the antigen ABA-KLH interfered with the induction of unresponsiveness to the idiotype. This interference is presumed to be mediated by prior activation of anti-idiotypic cells and/or antibody because injection of antigen with tolerogenic idiotype did not abrogate tolerance induction. FAU - Ortiz-Ortiz, L AU - Ortiz-Ortiz L FAU - Weigle, W O AU - Weigle WO FAU - Parks, D E AU - Parks DE LA - eng GR - AG01629/AG/NIA NIH HHS/United States GR - AI07007/AI/NIAID NIH HHS/United States GR - RRO-5514/RR/NCRR NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Exp Med JT - The Journal of experimental medicine JID - 2985109R RN - 0 (Immunoglobulin Idiotypes) RN - 7334-23-8 (p-Azobenzenearsonate) SB - IM MH - Animals MH - Antibody Formation MH - *Immune Tolerance MH - Immunization MH - Immunization, Passive MH - Immunization, Secondary MH - Immunoglobulin Idiotypes/analysis/*immunology MH - Male MH - Mice MH - Mice, Inbred A MH - p-Azobenzenearsonate/immunology PMC - PMC2186787 EDAT- 1982/09/01 00:00 MHDA- 1982/09/01 00:01 PMCR- 1983/03/01 CRDT- 1982/09/01 00:00 PHST- 1982/09/01 00:00 [pubmed] PHST- 1982/09/01 00:01 [medline] PHST- 1982/09/01 00:00 [entrez] PHST- 1983/03/01 00:00 [pmc-release] AID - 82267762 [pii] AID - 10.1084/jem.156.3.898 [doi] PST - ppublish SO - J Exp Med. 1982 Sep 1;156(3):898-911. doi: 10.1084/jem.156.3.898.